Company news

BridgeBio Oncology Therapeutics, Inc. news in 2026

BridgeBio Oncology Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

BBOT Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

November 10, 2026

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

October 12, 2026

BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers

September 8, 2026

BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

August 11, 2026

BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress

May 12, 2026

BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026

April 22, 2026

BBOT Presents Preclinical Data Showing RAS: PI3Kα Breaker BBO-10203 Inhibits PI3Kα/AKT Signaling in HER2AMP Models at the AACR Annual Meeting 2026

April 21, 2026

BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma

April 20, 2026

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 12, 2026

BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

March 18, 2026

BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor

March 6, 2026

BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress

March 5, 2026

BBOT to Participate in Upcoming Investor Healthcare Conferences

February 12, 2026

BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs

January 6, 2026

Decks in 2026